A Multi-Center, Open-Label, Study to Evaluate the Safety and Efficacy of Ublituximab (TG-1101) in Combination With TGR-1202 for Patients Previously Enrolled in Protocol UTX-TGR-304
What is the purpose of this trial?
This is a multi-center, open-label, study to evaluate the safety and efficacy of ublituximab (TG-1101) in combination with TGR-1202 for patients who have progressed on treatment arms previously enrolled in Protocol UTX-TGR-304
- Trial withTG Therapeutics, Inc.
- Start Date11/03/2016
- End Date08/31/2019
- Last Updated02/22/2018
- Study HIC#1604017653